Bioabsorbable Closure Articles & Analysis: Older

3 news found

Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical Electrophysiology

In both the U.S. and Europe, VASCADE MVP is now the first and only vascular closure system designed and labeled specifically for multi-site venous closure following electrophysiology procedures. ...

Oct. 30, 2019

ByCardival Medical, Inc.

Cardiva Medical Announces FDA Approval of the VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure Following Electrophysiology Procedures

Food and Drug Administration (FDA) for the VASCADE® MVP Venous Vascular Closure System. VASCADE MVP is the first and only vascular closure system designed and labeled specifically for multi-site venous closure – for 6-12 French inner diameter sheaths. ...

Dec. 18, 2018

ByCardival Medical, Inc.

Cardiva Medical Announces Positive Results of the AMBULATE Pivotal Study Evaluating the VASCADE MVP System Compared to Manual Compression for Multi-Vessel Closure Following Electrophysiology Procedures

& Chicago - November 10, 2018 - Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that VASCADE® MVP, the first vascular closure system designed specifically for multi-access venous closure following electrophysiology procedures such as arrhythmia ablation, met its endpoints compared to manual ...

Nov. 10, 2018

ByCardival Medical, Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you